Summary: In male patients with diabetes mellitus-induced erectile dysfunction (DMED), combination therapy with moxibustion plus low-dose tadalafil (5 mg daily)…
Browsing: Diabetes
Evidence summaries and landmark trials across type 1, type 2, prevention, glycaemic control, complications, and diabetes technology.
Summary: In 43 adults with type 2 diabetes using the forDiabetes mobile application, four weeks of using the forDiabetes mobile…
Clinical Context Curcumin, the principal bioactive compound in turmeric (Curcuma longa), has been studied extensively for anti-inflammatory, antioxidant, and metabolic…
Summary: In patients with diabetic foot osteomyelitis (DFO), oral N-acetyl-cysteine (NAC) 600 mg twice daily as an adjuvant therapy significantly…
A crossover trial finds a moderate-FODMAP diet plus metformin lowers postprandial glucose and raises GLP-1 in prediabetes, with microbiota shifts. PICO summary and commentary.
A prespecified DARE-19 analysis found dapagliflozin was safe and well tolerated in hospitalised COVID-19 patients regardless of type 2 diabetes status, with no demonstrated efficacy benefit. PICO summary and expert commentary.
Summary: In type 2 diabetic patients undergoing single simple dental extractions, amoxicillin did not significantly reduce the risk of alveolar…
A double-blind RCT finds empagliflozin gives broader cardiometabolic benefit than sitagliptin or metformin as add-on therapy in type 2 diabetes. PICO summary and commentary.
An RCT finds a periodontal health programme improves oral hygiene and knowledge in older diabetic patients, but not oral-health quality of life. PICO summary and commentary.
A machine-learning analysis finds lower baseline periodontal severity and HbA1c predict better response to gum therapy in diabetes (random forest AUC 0.83). PICO summary and commentary.